Michael Kraut
Medical Oncology · Southfield, MINPI 1114926805
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $35,963 of the $42,288 with a category attached, or 85.0%. E.r. Squibb & Sons, L.L.C. accounts for 86.9% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2019 at $22,319 and has fallen 92.8% since, to $1,615 in 2022.
Across 91 payments — averaging $464.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$37K
- AstraZeneca$4K
- Bristol Myers Squibb$614
- Genentech USA, Inc.$154
- Lilly USA, LLC$91
- Merck$62
- plus $329 from 15 others
Across 8 payments — averaging $2496.57 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- GSK$15K
- E.r. Squibb & Sons, L.L.C.$4K
- AstraZeneca$1K
What the payments were for
- Consulting fees$3,2508%
- Speaking & faculty fees$35,96385%
- Travel & lodging$1,0482%
- Food & beverage$2,0285%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 37 | $36,742 |
| AstraZeneca(2 entities) | 16 | $4,297 |
| Bristol Myers Squibb | 3 | $614 |
| Genentech USA, Inc. | 4 | $154 |
| Lilly USA, LLC | 5 | $91 |
| Merck | 4 | $62 |
| Amgen | 4 | $57 |
| Pharmacyclics LLC, An Abbvie Company | 3 | $43 |
| Eisai Inc. | 2 | $37 |
| Jazz Pharmaceuticals Inc. | 1 | $25 |
| Novartis | 2 | $22 |
| Seagen Inc. | 1 | $17 |
| Clovis Oncology, Inc. | 1 | $17 |
| Boehringer Ingelheim | 1 | $17 |
| Exelixis Inc. | 1 | $16 |
| Puma Biotechnology, Inc. | 1 | $14 |
| Foundation Medicine, Inc. | 1 | $14 |
| Astellas Pharma US Inc | 1 | $13 |
| Shire North American Group Inc | 1 | $13 |
| Pfizer | 1 | $12 |
| EMD Serono, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$42,288 in reported general payments places this provider in the 85th percentile of 170 medical oncology providers in Michigan.
Other medical oncology in Southfield
- Anibal DrelichmanSouthfield$13K
- Harry ErbaAnn Arbor$1.1M
- Philip PhilipDetroit$494K
- Shirish GadgeelDetroit$413K
- Patricia Lo RussoDetroit$322K
- Ammar SukariDetroit$273K
- Sami BrakeGrand Rapids$251K
- Frank WeinbergAnn Arbor$195K
- Wajahat KhanGrosse Pointe Woods$190K
- Charles SchifferDetroit$165K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.